Novonesis A/S

CPSE:NSIS B Voorraadrapport

Marktkapitalisatie: DKK 197.8b

Novonesis Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Novonesis heeft een totaal eigen vermogen van €11.0B en een totale schuld van €2.0B, wat de schuld-eigenvermogensverhouding op 18.1% brengt. De totale activa en totale passiva bedragen respectievelijk €15.3B en €4.2B. De EBIT Novonesis is €525.0M waardoor de rentedekking 15.7 is. Het heeft contanten en kortetermijnbeleggingen van €260.8M.

Belangrijke informatie

18.1%

Verhouding schuld/eigen vermogen

€1.99b

Schuld

Rente dekkingsratio15.7x
Contant€260.80m
Aandelen€11.01b
Totaal verplichtingen€4.25b
Totaal activa€15.25b

Recente financiële gezondheidsupdates

Recent updates

These 4 Measures Indicate That Novozymes (CPH:NZYM B) Is Using Debt Reasonably Well

Sep 27
These 4 Measures Indicate That Novozymes (CPH:NZYM B) Is Using Debt Reasonably Well

An Intrinsic Calculation For Novozymes A/S (CPH:NZYM B) Suggests It's 22% Undervalued

Sep 05
An Intrinsic Calculation For Novozymes A/S (CPH:NZYM B) Suggests It's 22% Undervalued

Novozymes (CPH:NZYM B) Might Be Having Difficulty Using Its Capital Effectively

Jul 09
Novozymes (CPH:NZYM B) Might Be Having Difficulty Using Its Capital Effectively

Does Novozymes (CPH:NZYM B) Have A Healthy Balance Sheet?

Jun 24
Does Novozymes (CPH:NZYM B) Have A Healthy Balance Sheet?

Calculating The Fair Value Of Novozymes A/S (CPH:NZYM B)

May 02
Calculating The Fair Value Of Novozymes A/S (CPH:NZYM B)

Novozymes (CPH:NZYM B) Might Be Having Difficulty Using Its Capital Effectively

Apr 07
Novozymes (CPH:NZYM B) Might Be Having Difficulty Using Its Capital Effectively

Does Novozymes (CPH:NZYM B) Have A Healthy Balance Sheet?

Mar 26
Does Novozymes (CPH:NZYM B) Have A Healthy Balance Sheet?

Is Now The Time To Put Novozymes (CPH:NZYM B) On Your Watchlist?

Mar 12
Is Now The Time To Put Novozymes (CPH:NZYM B) On Your Watchlist?

Novozymes' (CPH:NZYM B) Profits Appear To Have Quality Issues

Feb 04
Novozymes' (CPH:NZYM B) Profits Appear To Have Quality Issues

Calculating The Fair Value Of Novozymes A/S (CPH:NZYM B)

Jan 29
Calculating The Fair Value Of Novozymes A/S (CPH:NZYM B)

Is Novozymes (CPH:NZYM B) Using Too Much Debt?

Dec 23
Is Novozymes (CPH:NZYM B) Using Too Much Debt?

Returns On Capital At Novozymes (CPH:NZYM B) Paint A Concerning Picture

Dec 05
Returns On Capital At Novozymes (CPH:NZYM B) Paint A Concerning Picture

A Look At The Intrinsic Value Of Novozymes A/S (CPH:NZYM B)

Oct 14
A Look At The Intrinsic Value Of Novozymes A/S (CPH:NZYM B)

These 4 Measures Indicate That Novozymes (CPH:NZYM B) Is Using Debt Reasonably Well

Sep 13
These 4 Measures Indicate That Novozymes (CPH:NZYM B) Is Using Debt Reasonably Well

The Returns On Capital At Novozymes (CPH:NZYM B) Don't Inspire Confidence

Aug 29
The Returns On Capital At Novozymes (CPH:NZYM B) Don't Inspire Confidence

Estimating The Fair Value Of Novozymes A/S (CPH:NZYM B)

Jul 13
Estimating The Fair Value Of Novozymes A/S (CPH:NZYM B)

Here's Why Novozymes (CPH:NZYM B) Can Manage Its Debt Responsibly

Jun 13
Here's Why Novozymes (CPH:NZYM B) Can Manage Its Debt Responsibly

Here's What's Concerning About Novozymes' (CPH:NZYM B) Returns On Capital

May 29
Here's What's Concerning About Novozymes' (CPH:NZYM B) Returns On Capital

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( €1.8B ) NSIS B } overtreffen de korte termijn passiva ( €1.6B ).

Langlopende schulden: De kortetermijnactiva van NSIS B ( €1.8B ) dekken de langetermijnschulden ( €2.6B ) niet.


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 15.7% ) NSIS B wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van NSIS B is de afgelopen 5 jaar gedaald van 36.2% naar 18.1%.

Schuldendekking: De schuld van NSIS B wordt goed gedekt door de operationele kasstroom ( 44.8% ).

Rentedekking: De rentebetalingen op de schuld van NSIS B worden goed gedekt door EBIT ( 15.7 x dekking).


Balans


Ontdek gezonde bedrijven